[ET Net News Agency, 18 August 2025] CLOVER BIO-B (02197) rose 19.7% to HK$0.79.
It hits an intra-day high of HK$0.8, hitting a 52-week high, and an intra-day low of HK$0.63. The total shares traded was 21.11 million, with a value of HK$14.94m. The active buy/sell ratio is 69:31, with net buying turnover of HK$5.51m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$528,941, with volume weighted average price of HK$0.704. CMB INT'L SEC accounts for greatest net responsive selling turnover of HK$1.28m, with volume weighted average price of HK$0.674. The stock has risen a combined 23.4% over the past 2 consecutive trading days.
Basic Information| Nominal | 0.790 | % Chg | +19.70% |
| High | 0.800 | Low | 0.630 |
| Shares Tr | 21.11m | Turnover | 14.94m |
| 10-D SMA | 0.633 | %H.V | 99.294 |
| 20-D SMA | 0.592 | VWAP | 0.708 |
| 50-D SMA | 0.419 | RSI14 | 78.523 |
Status: Hitting a 52-week high, active buy/sell ratio is 69:31, with net buying turnover of HK$5.51m, rising a combined 23.4% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| CLOVER BIO-B (02197) | 0.79 | +19.70 |
| INNOVENT BIO (01801) | 102.90 | +5.54 |
| XTALPI (02228) | 9.02 | -2.49 |
| WUXI BIO (02269) | 31.04 | +0.32 |
| WUXI APPTEC (02359) | 106.80 | -0.74 |
| CSTONE PHARMA-B (02616) | 8.88 | -4.31 |
| BEIGENE (06160) | 194.60 | +1.62 |
| ASCENTAGE-B (06855) | 91.00 | +5.69 |
| AKESO (09926) | 172.00 | +3.93 |
| REMEGEN (09995) | 80.55 | +4.47 |
(ed)
Nominal 